ibrutinib to treat chronic graft versus host disease
Published 7 years ago • 515 plays • Length 7:27Download video MP4
Download video MP3
Similar videos
-
9:28
david miklos, md, phd: ibrutinib in chronic graft-versus-host disease
-
2:31
ibrutinib for treating chronic gvhd
-
1:53
bringing ibrutinib to the frontline of chronic gvhd treatment
-
59:50
introduction to chronic graft versus host disease 2020
-
1:14
dr. jacobs on treating graft-versus-host-disease with ibrutinib in cll
-
4:41
despite toxicities, ibrutinib is beneficial for treatment-resistant graft-vs.-host disease
-
53:51
introduction to chronic graft-vs-host disease (gvhd) 2018
-
2:29
ruxolitinib and ibrutinib: the future for gvhd treatment?
-
1:05
limitations of ibrutinib and ruxolitinib use in cgvhd
-
22:19
updates in chronic graft-versus-host disease (gvhd) management
-
2:56
ibrutinib, ruxolitinib & belumosudil for sr-cgvhd
-
58:10
graft-versus-host disease: advances in prevention and treatment
-
1:06
ruxolitinib appears promising as treatment of chronic graft-versus-host disease
-
3:35
case 3: treating chronic graft-versus-host disease
-
1:00:28
introduction to chronic graft versus host disease 2016
-
56:36
overcoming the challenges of acute and chronic gvhd
-
50:13
chronic graft-vs-host disease (gvhd) of skin and connective tissues 2018
-
3:24
understanding the biology of chronic gvhd
-
51:28
graft-versus-host disease/graft-versus-leukemia: recent advances in therapy